Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a Cochrane Review and network meta‐analysis

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD013020Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 01 May 2018see what's new
Type:
  1. Intervention
Stage:
  1. Protocol
Cochrane Editorial Group:
  1. Cochrane Urology Group

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Yonas Mehari Tesfamariam

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Sascha Macherey

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Kathrin Kuhr

    Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany

  • Ingrid Becker

    Institute of Medical Statistics and Computational Biology, University Hospital of Cologne, Cologne, Germany

  • Ina Monsef

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Tina Jakob

    Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

  • Axel Heidenreich

    Department of Urology, University Hospital of Cologne, Cologne, Germany

  • Nicole Skoetz

    Correspondence to: Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

    [email protected]

Contributions of authors

Yonas Mehari Tesfamariam: wrote the protocol.

Sascha Macherey: content input.

Kathrin Kuhr: methods input.

Ingrid Becker: methods input.

Ina Mosef: search strategy development.

Tina Jakob: wrote the protocol.

Axel Heidenreich: clinical expertise.

Nicole Skoetz: wrote the protocol.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Federal Ministry for Education and Research (BMBF), Germany.

    Grant no: 01KG1702

Declarations of interest

Yonas Mehari Tesfamariam: none known.

Sascha Macherey: none known.

Kathrin Kuhr: none known.

Ingrid Becker: none known.

Ina Monsef: none known.

Tina Jakob: none known.

Axel Heidenreich: none known.

Nicole Skoetz: none known.

Acknowledgements

We would like to thank members of Cochrane Urology for their comments and improving the review.

This project is funded by the Federal Ministry for Education and Research, grant no. 01KG1702.

The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme.

Version history

Published

Title

Stage

Authors

Version

2020 Dec 03

Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a network meta‐analysis

Review

Tina Jakob, Yonas Mehari Tesfamariam, Sascha Macherey, Kathrin Kuhr, Anne Adams, Ina Monsef, Axel Heidenreich, Nicole Skoetz

https://doi.org/10.1002/14651858.CD013020.pub2

2018 May 01

Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a Cochrane Review and network meta‐analysis

Protocol

Yonas Mehari Tesfamariam, Sascha Macherey, Kathrin Kuhr, Ingrid Becker, Ina Monsef, Tina Jakob, Axel Heidenreich, Nicole Skoetz

https://doi.org/10.1002/14651858.CD013020

Notes

We have based parts of the Methods section of this protocol on a standard template developed by the Cochrane Metabolic and Endocrine Disorders Group, which has been modified and adapted for use by the Cochrane Urology Group. In addition, this protocol is partly based on suggested wording from the Pain, Palliative and Supportive Care Review Group (PaPaS CRG), the Cochrane Heamatological Malignancies Review Group and the protocol templates for a Cochrane intervention review that compares multiple interventions (Chaimani 2014; Chaimani 2017).

Keywords

MeSH

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.

Direct and indirect comparisons of interventions (strength of line represents number of trials evaluating the comparison; dotted lines are indirect comparisons).
Figures and Tables -
Figure 1

Direct and indirect comparisons of interventions (strength of line represents number of trials evaluating the comparison; dotted lines are indirect comparisons).